{"compound":{"slug":"retatrutide","name":"Retatrutide","aliases":["ly3437943"],"class":"glp1","one_liner":"An investigational triple receptor agonist being studied in clinical development.","status_note":"Investigational and not approved for human use outside authorised research."},"summary":"No structured Retatrutide reports are published yet. New reports are reviewed before they enter the aggregate.","aggregate":{"total":0,"outcomes":{"positive":{"count":0,"pct":0},"mixed":{"count":0,"pct":0},"negative":{"count":0,"pct":0},"no_effect":{"count":0,"pct":0}},"topEffects":[],"topSideEffects":[],"medianOnsetDays":null,"doses":[],"wouldRepeat":{"yes":0,"answered":0,"pct":null},"sources":{"reddit":0,"forum":0,"youtube":0,"user":0},"unmappedEffects":[]},"methodology":"Source-linked public reports are normalised into structured fields. Percentages use the full published report count shown. Anecdotal evidence is not clinical data.","canonical_url":"https://anecdotal.health/compound/retatrutide","generated_at":"2026-08-23T02:30:08.813Z"}